Yuyu Pharma, Inc. (KRX: 000220)

Yuyu Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	42,861	30,605	25,839	50,263	20,323	26,846
Trading Asset Securities	1,024	1,749	4,939	-	180	-
Cash & Short-Term Investments	43,885	32,354	30,778	50,263	20,503	26,846
Cash Growth	130.84%	5.12%	-38.77%	145.15%	-23.63%	-2.42%
Accounts Receivable	17,499	20,801	21,940	19,528	17,782	18,752
Other Receivables	1,961	3,653	2,876	3,265	2,125	1,748
Receivables	19,460	24,455	24,816	22,793	19,908	20,500
Inventory	42,080	44,152	39,832	25,225	23,689	17,016
Prepaid Expenses	293.72	341.03	238.84	115.08	97.7	149.81
Other Current Assets	338.85	294.62	692.94	491.06	269.6	541.76
Total Current Assets	106,057	101,597	96,358	98,888	64,467	65,054
Property, Plant & Equipment	80,951	81,403	81,371	80,341	78,073	63,263
Long-Term Investments	7,448	6,867	5,944	5,712	5,077	4,026
Goodwill	503.22	503.22	50.83	50.83	50.83	50.83
Other Intangible Assets	3,121	3,764	3,666	4,087	3,786	1,925
Long-Term Accounts Receivable	0	-	493.76	345.28	632.98	764.51
Long-Term Deferred Tax Assets	-	-	-	-	-	108.34
Other Long-Term Assets	2,725	4,079	6,826	3,561	2,814	2,528
Total Assets	200,805	198,214	195,205	192,985	154,901	137,719
Accounts Payable	8,206	10,952	15,841	8,982	5,287	6,385
Accrued Expenses	1,396	1,504	1,613	1,553	1,312	997.87
Short-Term Debt	32,975	24,482	36,164	8,200	3,500	22,560
Current Portion of Long-Term Debt	1,658	448.73	718.28	1,812	888.5	877.15
Current Portion of Leases	587.94	455.55	542.86	414.94	589.67	434.92
Current Income Taxes Payable	754.84	574.8	297.04	219.32	-	1,421
Other Current Liabilities	16,726	11,558	9,140	8,832	6,821	9,820
Total Current Liabilities	62,303	49,975	64,316	30,015	18,399	42,496
Long-Term Debt	50.04	13,640	1,600	28,456	14,592	2,683
Long-Term Leases	372.23	380.92	250.96	282.81	379.95	387.56
Long-Term Deferred Tax Liabilities	4,001	4,360	3,690	2,897	1,809	-
Other Long-Term Liabilities	216.08	7,215	242.12	158.07	212.16	348.21
Total Liabilities	69,553	77,858	71,831	64,300	37,865	47,174
Common Stock	17,609	17,609	17,609	17,609	8,412	6,745
Additional Paid-In Capital	64,667	65,075	58,803	58,803	53,467	35,319
Retained Earnings	29,586	20,171	31,396	36,540	41,914	42,717
Treasury Stock	-5,791	-5,791	-6,156	-4,371	-4,371	-3,686
Comprehensive Income & Other	12,980	12,531	12,572	13,107	13,639	6,302
Total Common Equity	119,052	109,595	114,224	121,689	113,062	87,397
Minority Interest	9,607	8,168	6,558	4,404	2,677	1,850
Shareholders' Equity	131,251	120,356	123,374	128,685	117,036	90,545
Total Liabilities & Equity	200,805	198,214	195,205	192,985	154,901	137,719
Total Debt	35,643	39,407	39,276	39,166	19,950	26,943
Net Cash (Debt)	8,242	-7,053	-8,499	11,097	552.89	-96.32
Net Cash Growth	-	-	-	1907.08%	-	-
Net Cash Per Share	402.76	-433.55	-512.57	695.34	46.01	-6.42
Filing Date Shares Outstanding	16.18	16.18	16.35	16.66	14.92	11.76
Total Common Shares Outstanding	16.18	16.18	16.35	16.66	14.92	11.76
Working Capital	43,754	51,621	32,042	68,873	46,068	22,558
Book Value Per Share	7356.73	6772.38	6985.77	7306.09	7579.20	7433.21
Tangible Book Value	115,428	105,327	110,506	117,551	109,226	85,422
Tangible Book Value Per Share	7132.80	6508.66	6758.42	7057.65	7322.03	7265.19
Land	32,297	30,380	30,380	30,380	30,380	20,934
Buildings	51,954	53,397	52,138	48,966	48,912	43,199
Machinery	40,422	39,229	37,067	33,334	30,809	28,738
Construction In Progress	887.07	259.36	1,333	3,454	202.8	1,741

Source: S&P Capital IQ. Standard template. Financial Sources.